{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:01:36Z","timestamp":1784797296713,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The gut microbiome has emerged as an important modulator of cardiovascular diseases, yet data on aortic valve disorders, particularly aortic stenosis (AS), remain limited. This study aimed to characterize gut microbiome differences in patients with bicuspid (BS) and tricuspid aortic stenosis (TS) using aortic regurgitation (AR) patients as a clinically comparable control group with similar age distribution, comorbidities, and metabolic profiles. A total of 122 patients were included in this prospective cross-sectional study: 33 AR, 22 BS, and 67 TS patients. Microbiome profiling was conducted from anal swabs using 16S rRNA gene sequencing. Beta diversity was assessed via UniFrac distances, and computed redundancy analysis was performed using linear discriminant analysis effect size. The groups were largely homogeneous regarding most clinical characteristics; AR patients showed only marginally worse renal function, while BS patients were slightly younger with fewer cases of diabetes. In beta diversity analyses, both TS and BS patients exhibited clearly distinct microbiome compositions compared with AR controls, independent of clinical parameters used as potential confounders. TS and BS patients differed only minimally from each other. AR patients showed higher abundances of Bacteroides, Faecalibacterium, Lachnoclostridium, and Alistipes, whereas AS patients exhibited increased levels of Corynebacterium, Anaerococcus, Peptoniphilus, and Finegoldia. Co-abundance network analysis revealed that AS patients displayed an extensive and highly interconnected bacterial network, characterized by strong correlations among taxa such as Bacteroides, Alistipes, Parabacteroides, and Faecalibacterium, rather than isolated changes in individual taxa. AR patients provide a clinically suitable control group for AS. AS patients show a distinct microbiome composition and a highly interconnected microbial network with three major hubs, warranting further mechanistic investigation.<\/jats:p>","DOI":"10.1038\/s41598-026-63354-w","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:59:16Z","timestamp":1784793556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiome composition differs between aortic stenosis and aortic regurgitation patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Benedikt","family":"Bartsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetozar","family":"Nesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muntadher","family":"Al Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Nicolas","family":"Jamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Ackerschott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"L\u00fcbbering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Billig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijo","family":"Parcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Hamiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Bakhtiary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Katharina","family":"Weisheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"63354_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ejcts\/ezaf276","volume":"67","author":"F Praz","year":"2025","unstructured":"Praz, F. et al. 2025 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. J. Cardio-Thoracic Surg. 67, 276 (2025).","journal-title":"Eur. J. Cardio-Thoracic Surg."},{"key":"63354_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","volume":"40","author":"PR Goody","year":"2020","unstructured":"Goody, P. R. et al. Aortic valve stenosis: From basic mechanisms to novel therapeutic targets. Arterioscler. Thromb. Vasc. Biol. 40, 885\u2013900. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313067 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"63354_CR3","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1161\/CIRCRESAHA.110.234146","volume":"108","author":"SE New","year":"2011","unstructured":"New, S. E. & Aikawa, E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ. Res. 108, 1381\u20131391 (2011).","journal-title":"Circ. Res."},{"key":"63354_CR4","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41587-020-0549-5","volume":"38","author":"PB Chen","year":"2020","unstructured":"Chen, P. B. et al. Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis. Nat. Biotechnol. 38, 1288\u20131297 (2020).","journal-title":"Nat. Biotechnol."},{"key":"63354_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aav3487","volume":"366","author":"C Gil-Cruz","year":"2019","unstructured":"Gil-Cruz, C. et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science 366, 881\u2013886 (2019).","journal-title":"Science"},{"key":"63354_CR6","doi-asserted-by":"crossref","unstructured":"Jobin, K. et al. A high-salt diet compromises antibacterial neutrophil responses through hormonal perturbation. Sci. Transl. Med. 12 (2020).","DOI":"10.1126\/scitranslmed.aay3850"},{"key":"63354_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s42255-022-00649-y","volume":"4","author":"S Qiao","year":"2022","unstructured":"Qiao, S. et al. Gut Parabacteroides merdae protects against cardiovascular damage by enhancing branched-chain amino acid catabolism. Nat. Metab. 4, 1271\u20131286. https:\/\/doi.org\/10.1038\/s42255-022-00649-y (2022).","journal-title":"Nat. Metab."},{"key":"63354_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/life14040527","volume":"14","author":"G Nayak","year":"2024","unstructured":"Nayak, G. et al. Gut microbiome and its role in valvular heart disease: Not a \u201cgutted\u201d relationship. Life 14, 527 (2024).","journal-title":"Life"},{"key":"63354_CR9","unstructured":"Nishijima, S. et al. Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations. Cell (2024)."},{"key":"63354_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2018.11.038","volume":"284","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease. Atherosclerosis 284, 121\u2013128 (2019).","journal-title":"Atherosclerosis"},{"key":"63354_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-03071-w","volume":"23","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Alterations in gut microbiota and host transcriptome of patients with coronary artery disease. BMC Microbiol. 23, 320 (2023).","journal-title":"BMC Microbiol."},{"key":"63354_CR12","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1039\/D1FO03942C","volume":"13","author":"D Taladrid","year":"2022","unstructured":"Taladrid, D., de Celis, M., Belda, I., Bartolom\u00e9, B. & Moreno-Arribas, M. V. Hypertension-and glycaemia-lowering effects of a grape-pomace-derived seasoning in high-cardiovascular risk and healthy subjects. Interplay with the gut microbiome. Food Funct. 13, 2068\u20132082 (2022).","journal-title":"Food Funct."},{"key":"63354_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129795","volume":"10","author":"IM Velsko","year":"2015","unstructured":"Velsko, I. M. et al. Fusobacterium nucleatum alters atherosclerosis risk factors and enhances inflammatory markers with an atheroprotective immune response in ApoEnull mice. PLoS ONE 10, 0129795 (2015).","journal-title":"PLoS ONE"},{"key":"63354_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.798685","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J., Liu, L., Wu, P., Zhao, L. & Wu, Y. Fusobacterium nucleatum accelerates atherosclerosis via macrophage-driven aberrant proinflammatory response and lipid metabolism. Front. Microbiol. 13, 798685 (2022).","journal-title":"Front. Microbiol."},{"key":"63354_CR15","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida, N. et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 138, 2486\u20132498 (2018).","journal-title":"Circulation"},{"key":"63354_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69983-z","volume":"10","author":"N Yoshida","year":"2020","unstructured":"Yoshida, N. et al. A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases. Sci. Rep. 10, 13009. https:\/\/doi.org\/10.1038\/s41598-020-69983-z (2020).","journal-title":"Sci. Rep."},{"key":"63354_CR17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/obr.12750","volume":"19","author":"IC van den Munckhof","year":"2018","unstructured":"van den Munckhof, I. C. et al. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: A systematic review of human studies. Obes. Rev. 19, 1719\u20131734 (2018).","journal-title":"Obes. Rev."},{"key":"63354_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082679","volume":"13","author":"H-J Tsai","year":"2021","unstructured":"Tsai, H.-J. et al. Gut microbiota and subclinical cardiovascular disease in patients with type 2 diabetes mellitus. Nutrients 13, 2679 (2021).","journal-title":"Nutrients"},{"key":"63354_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-022-00273-4","volume":"8","author":"Y-Y Cai","year":"2022","unstructured":"Cai, Y.-Y. et al. Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis. NPJ Biofilms Microbiomes 8, 11. https:\/\/doi.org\/10.1038\/s41522-022-00273-4 (2022).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"63354_CR20","unstructured":"Yang, C. et al. Gut microbiota as predictive biomarker for chronic heart failure in patients with different nutritional risk. J. Cardiovasc. Transl. Res., 1\u201318 (2024)."},{"key":"63354_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tim.2022.08.003","volume":"31","author":"B Jia","year":"2023","unstructured":"Jia, B., Zou, Y., Han, X., Bae, J.-W. & Jeon, C. O. Gut microbiome-mediated mechanisms for reducing cholesterol levels: Implications for ameliorating cardiovascular disease. Trends Microbiol. 31, 76\u201391 (2023).","journal-title":"Trends Microbiol."},{"key":"63354_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jn\/nxz289","volume":"150","author":"AM Tindall","year":"2020","unstructured":"Tindall, A. M., McLimans, C. J., Petersen, K. S., Kris-Etherton, P. M. & Lamendella, R. Walnuts and vegetable oils containing oleic acid differentially affect the gut microbiota and associations with cardiovascular risk factors: Follow-up of a randomized, controlled, feeding trial in adults at risk for cardiovascular disease. J. Nutr. 150, 806\u2013817 (2020).","journal-title":"J. Nutr."},{"key":"63354_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1849998","volume":"12","author":"M Van Hul","year":"2020","unstructured":"Van Hul, M. et al. From correlation to causality: The case of Subdoligranulum. Gut Microbes 12, 1849998 (2020).","journal-title":"Gut Microbes"},{"key":"63354_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 8, 845 (2017).","journal-title":"Nat. Commun."},{"key":"63354_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151\u20131156 (2018).","journal-title":"Science"},{"key":"63354_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01421","volume":"11","author":"T Trautmann","year":"2020","unstructured":"Trautmann, T. et al. The impact of oral sodium chloride supplementation on thrive and the intestinal microbiome in neonates with small bowel ostomies: A prospective cohort study. Front. Immunol. 11, 1421. https:\/\/doi.org\/10.3389\/fimmu.2020.01421 (2020).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63354-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63354-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63354-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:14:18Z","timestamp":1784794458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63354-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63354"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63354-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23073"}}